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Abstract
Background: Genetic variation in the innate immune system of the host may play a role in
determining the risk of developing infection, as well as outcome from infection.
Methods:  Infectious complications were retrospectively determined in 293 (233 African-
American (AA), 57 Caucasian and 3 Hispanic) mechanically ventilated very low birth weight
(VLBW) infants (<1500 grams at birth) who were genotyped for the IL-6 -174 G/C, IL-10 -1082 G/
A and CD14 -260 C/T single nucleotide polymorphisms (SNPs).
Results: The IL-6 -174C allele was associated with an increased incidence of late blood stream
infection (BSI) in AA but not Caucasian infants. In AA infants with the C allele the incidence of late
BSI was 20/29 (69%) compared to 94/204 (46%) in homozygous GG infants (RR 2.6, 95% CI: 1.1–
6.0, p = 0.021). The IL-10 -1082A allele was associated with an increased incidence of late BSI. One
or more episodes of late BSI developed in 14 (35%) of 40 infants with the GG genotype, 71 (49%)
of 145 infants with the GA genotype and 63 (58%) of 108 infants with the AA genotype (p = 0.036).
Infants with the A allele (AA or GA genotypes) had an incidence of late BSI that was 134/253 (53%)
compared to 14/40 (35%) in homozygous GG infants (RR 2.1, 95% CI: 1.04–4.19, p = 0.035). The
CD14 -260 C/T SNP did not alter the overall risk for BSI in ventilated VLBW infants. Multiple BSI
episodes were more common in the TT genotype group (CC: 17%, CT: 11%, TT: 30%, p = 0.022).
This effect was due to the strong effect of the TT genotype on the incidence of multiple BSI in AA
infants (CC: 15%, CT: 11%, TT: 39%, p = 0.003).
Conclusion: The IL-6 -174 G/C, IL-10 -1082 G/A and CD14 -260 C/T SNPs may alter risk for BSI
in ventilated VLBW infants.
Background
Sepsis is a persistent and vexing problem in very low birth
weight (VLBW) infants. The development of sepsis in this
population has several adverse implications including;
prolongation of hospitalization, development of chronic
lung disease, adverse neurodevelopmental outcome and
excess mortality [1]. The incidence of one or more epi-
sodes of late onset blood stream infection (BSI) in this
population ranges from 25–30% with higher rates for
infants with birth weights less than 1000 grams [2-5].
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Genetic variation in the innate immune system of the host
may play a role in determining the risk of developing and
outcome from infection. Variation in the ability to recog-
nize pathogens may influence the risk of infection. One of
the primary molecules that function in recognition of
pathogens is CD14. CD14 is expressed on phagocytic
cells, and along with LPS-binding protein, it acts to trans-
fer lipopolysaccharide (LPS) and other bacterial ligands to
the Toll-like receptor 4 (TLR4)/MD-2 signaling complex
[6]. The engagement of CD14 and LPS-binding protein
during recognition of Gram-negative bacteria results in
activation of a complex of innate host defense mecha-
nisms. CD14 expression is influenced by a single nucle-
otide polymorphism (SNP) found in the proximal CD14
promoter. A C to T substitution 260 base pairs (bp) prior
to the start codon diminishes binding of the inhibitory
factor sp3 resulting in increased expression of the CD14
gene [7,8]. Homozygous carriers of the T allele have sig-
nificant increases in both soluble and membrane-bound
CD14 [9]. The CD14 -260 T allele may increase modify
the risk for septic shock [10].
Variation in the magnitude of inflammatory response
may also influence the risk of sepsis. Outcome from sepsis
depends to a considerable degree on the host response.
While an absent or diminished host response leads to
overwhelming infection, an excessive response can lead to
systemic inflammation and multiple organ failure [11-
15].
Interleukin-6 (IL-6) is a proinflammatory cytokine that
plays an important role in the host response to infection
[16]. The C allele of IL-6 -174 G/C promoter polymor-
phism is associated with increased IL-6 production in
newborn infants [17]. The IL-6 -174 G/C SNP has been
inconsistently associated with altered risk for and out-
come from sepsis in several studies [18,19].
Interleukin-10 (IL-10) is an anti-inflammatory cytokine
produced by macrophages and T-helper-type II (TH2)
lymphocytes that downregulates inflammatory mediator
production by stimulated immune and epithelial cells
[20-22]. Thus, IL-10 can potentially counterbalance the
detrimental effects of excessive cytokine production in
sepsis. The SNP at -1082 (G to A) modifies IL-10 secretion
and may influence outcome in several disease states [23-
25]. The IL-10 -1082 G/A SNP lies within a putative Ets
transcription site and is associated (A allele) with lower
IL-10 production in vitro [26]. The IL-10 -1082 SNP may
modify the response to sepsis from a variety of organisms
[23,27].
Variation in the IL-10, IL-6 and CD14 genes may be
genetic factors influencing the development and outcome
of sepsis in the premature newborn. The purpose of this
study was to determine if there is a relationship between
the IL-10 -1082 G/A, IL-6 -174 G/C and CD14 -260 C/T
SNPs and risk for or outcome from sepsis in mechanically
ventilated very low birth weight (VLBW) infants.
Methods
The genomic DNA used for this case controlled study was
extracted from archival tracheal aspirate (TA) pellets
(259) or blood (34 patients) collected prospectively as
part of an ongoing study of genetic factors in the develop-
ment of complications of prematurity. The TAs that were
used as a source of genomic DNA were originally collected
as part of long term longitudinal studies examining
cytokine concentrations and the development of CLD
[28,29]. Infants were included in the study if they fulfilled
the following inclusion criteria: birth weight less than
1500 grams, mechanical ventilation (MV) during the first
week of life, complete clinical data on infectious outcome
and genomic DNA sample that could be used for genotyp-
ing. Infants were excluded if complete data on outcome
were not available or suitable DNA was not available. In
order to compare the frequency of the various polymor-
phisms with normal term infants, control DNA was
extracted from cord blood spots from a random sample of
168 African-American and 96 Caucasian term infants
(performed independently as part of another study exam-
ining genotype and asthma). Consent was obtained from
the parents of study infants to use the TAs and blood sam-
ples. The study was approved by the Institutional Review
Board for Human Research at Louisiana State University
Health Sciences Center in Shreveport.
Cultures for genital mycoplasmas were performed on TA
samples collected in the first few days of life. Clinical and
outcome data were abstracted from the clinical record and
included information on respiratory outcome, survival
and development of complications of prematurity. The
results of all cultures of blood, tracheal aspirates and cer-
ebrospinal fluid were recorded from the patients' charts.
Tracheal aspirates were obtained twice a week in all intu-
bated patients according to unit policy. Infants were eval-
uated for sepsis at the discretion of the clinical staff when
signs and symptoms compatible with sepsis developed.
Generally, 2 blood cultures from separate sites were
obtained when assessing infants for blood stream infec-
tion. For the purposes of this study any positive blood cul-
ture was considered a blood stream infection (bacteremia
or fungemia). Blood stream infections (BSI) were divided
into early if the culture was obtained during the first 3
days of life, and late (nosocomial) if it was obtained there-
after. Nosocomial pneumonia was diagnosed when there
was radiological evidence of a new pulmonary infiltrate
and the blood and endotracheal aspirate culture grew the
same organism. Isolation of an organism from a TA cul-
ture in an infant greater than 3 days of age without a pos-BMC Medicine 2006, 4:10 http://www.biomedcentral.com/1741-7015/4/10
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itive blood culture or a change in chest radiograph was
considered colonization. Sepsis mortality was defined as
mortality during an acute episode of sepsis.
Laboratory methods
Isolation of total DNA from blood or TA pellets was per-
formed using the QIAmp DNA Mini kits™ (Qiagen Incor-
porated, Chatsworth, CA). Briefly, TA pellets were
suspended in 200 µl of sterile phosphate buffered saline
by vigorous vortexing, then digested with proteinase K
and applied to silica gel spin columns. Columns were
washed with the manufacturer's supplied buffers and the
total DNA was eluted in 200 µl elution buffer. Blood (200
µl) was extracted similarly to the TA pellets.
The IL-10 -1082 G/A and IL-6 -174 G/C SNPs were geno-
typed using published allele specific PCR methods
[25,30]. The CD14 -26/0 CT SNP was genotyped using a
published restriction fragment length polymorphism
method [9].
Data analysis
Data analysis consisted of comparing the incidence of
infections and their complications between the various
genotypes. All statistical analysis was performed using
SPSS for Windows version 6.0 (SPSS Inc., Chicago, IL).
Differences in frequencies of complications were assessed
by Chi square. ANOVA or the Student t-test was used to
assess normally distributed variables where appropriate.
The Wilcox Rank Sum test was used for analysis of factors
that were not normally distributed. A probability value of
less than 0.05 was considered statistically significant. The
data are presented as mean ± standard error of the mean
(SEM).
Results
Two hundred and ninety-three (293) patients had com-
plete culture and clinical information. Two hundred and
thirty-three (79%) were African-American, 57 (20%) were
Caucasian and 3 (1%) were Hispanic. Mean gestational
age and mean birth weight of the study population were
26.7 ± 0.1 weeks and 906 ± 13 grams, respectively. Male:
female ratio was 176:117. All patients required MV at
birth and 264 (90%) infants were treated with exogenous
surfactant therapy (Survanta®, Ross Products Division,
Abbott Laboratories, Columbus, OH). One hundred and
fifty eight (54%) infants were oxygen dependent at 28
days and 64 (22%) were oxygen dependent at 36 weeks
PCA. There were 40 (14%) patients who died during their
initial hospitalization (25 before 28 days of age and 15
after 28 days). Late onset BSI was the major cause of late
mortality in ventilated VLBW infants with 14/15 deaths
occurring after 28 days of age directly attributable to BSI
(RR 15.3, 95% CI 2.0–117.9; p < 0.001).
One patient had positive blood cultures (Group B strepto-
cocci) during the first 3 days of life (early BSI) and 147
(50%) had one or more episodes of late (nosocomial)
BSI. Coagulase negative staphylococci (CONS) were the
organisms most commonly isolated from blood cultures.
Seventy-one (24%) infants had one or more episodes of
bacteremia/fungemia other than from CONS and 46
(15.7%) had multiple episodes of bacteremia or fun-
gemia. Organisms causing nosocomial BSI (bacteremia/
fungemia) for the study population are shown in Table 1.
There were 15 (5%) deaths directly attributable to sepsis.
Fourteen of 15 sepsis related deaths were associated with
a non-CONS BSI (p < 0.001, RR = 59; 95% CI 7–421).
Endotracheal (ET) cultures obtained during the first 3
days of life grew Ureaplasma urealyticum in 86 (29%), Myc-
oplasma hominis in 35 (12%) and other bacteria in 12
(4%) infants. Subsequent bacterial colonization of the
endotracheal tube (ETT) was detected in 145 (49%)
patients. After birth, ETTs were most commonly colonized
with CONS, less frequently with other organisms (Table
1). Nosocomial pneumonia was diagnosed in 22 (7%)
infants (Table 1).
Table 1: Organisms causing Nosocomial Blood Stream Infection, Pneumonia and Endotracheal tube colonization in ventilated VLBW 
infants
CONS Fungi Gram negative bacilli Enterococci sp. Staphylococcus aureus Other
Episodes of Nosocomial BSI 113 (56)a 33 (16) 26 (13) 9 (4) 6 (3) 14 (7)
ETT Colonization (patients) 136 (46) 27 (9) 39 (13) 27 (9) 14 (5) 30 (10)
Episodes of Nosocomial Pneumonia 1 (5) 7 (32) 10 (45) 0 3 (14) 1 (5)
Sepsis Related Deaths 0 6 5 2 0 2
a Numbers represent the number of episodes of infections (blood stream and pneumonia) or the number of patients with ETT colonization by a 
particular organism. Numbers in parentheses represent the percentages of total infections (bacteremia and pneumonia) or percentage of all patients 
(ETT colonization rates). Infants may have been simultaneously or serially colonized with more than one organism, thus the sum of the organism-
specific rates is greater than the overall rate of ETT colonization (49%).
CONS coagulase negative staphylococci
ETT endotracheal tube
BSI blood stream infectionsBMC Medicine 2006, 4:10 http://www.biomedcentral.com/1741-7015/4/10
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IL-6 -174 G/C polymorphism and infectious complications
The frequency of the IL-6 -174 C allele in the study popu-
lation was 0.128. The frequency of the C allele was signif-
icantly less in African-American (0.07) than in Caucasian
infants (0.385) (p < 0.001). Two hundred and four
(87.6%) African-American infants were homozygous GG,
27 (11.6%) were heterozygous GC and 2 (0.8%) were
homozygous CC. In Caucasian infants the distribution of
genotypes was: 19 (33.3%) GG, 32 (56.1%) GC and 6
(10.5%) CC. The 3 Hispanic infants were all GG. There
were no differences in the frequency of the IL-6 -174C
allele between study infants and ethnically matched con-
trol (term) infants [see Additional File 1].
Birth weight, gestational age, gender, TA isolation of Uu or
Mh and need for surfactant replacement did not differ
among genotype groups in either Caucasian or African
American infants. Because the frequency of the IL-6 -174C
allele was significantly different between ethnic groups,
the effects of this SNP on infectious complications were
analyzed separately for Caucasian and African-American
infants.
The IL-6 -174C allele was associated with an increased
incidence of late BSI in African-American infants. One or
more episodes of late BSI developed in 94 (46%) of 204
infants with the GG genotype, 18 (67%) of 27 infants
with the GC genotype and 2 (100%) of 2 infants with the
CC genotype (p = 0.046). In infants who had the C allele
(CC or GC genotypes) the incidence of late BSI was 20/29
(69%) compared to 94/204 (46%) in infant who were
homozygous GG (RR 2.6, 95% CI: 1.1–6.0, p = 0.021).
There were no significant differences in organism-specific
BSI rates among genotype groups (Table 2). Neither the
rates of non-CONS BSI (GG: 24%, GC: 44%, CC: 0%; p =
0.116) or multiple BSI episodes (GG: 15%, GC: 19%, CC:
0%, p = 0.752) were different among genotype groups.
The IL-6 -174 G/C polymorphism had no effect on sepsis-
related mortality in African-American infants. Overall sep-
sis mortality was (GG: 5%, GC: 4%, CC: 0%; p = 0.916).
The rate of sepsis mortality for African-American infants
with late BSI was (GG: 11%, GC: 6%, CC: 0%; p = 0.717).
The rate of colonization of ETT tubes and incidence of
nosocomial pneumonia were not affected by the IL-6 -174
G/C SNP. Nosocomial pneumonia rates were: (GG: 8%,
GC: 7%, CC: 0%; p = 0.909). ETT colonization rates were
25/54 (46%) for infants with the GG genotype, 68/128
(53%) GC genotype, and 52/113 (46%) CC genotype (p
= 0.489). CONS were the most common bacteria coloniz-
ing the ET tube in both groups. Organism-specific coloni-
zation rates were not different among genotype groups.
In contrast to that observed in African-American infants,
the IL-6 -174 G/C SNP had no effect on the incidence of
late BSI in Caucasian infants. One or more episodes of late
BSI developed in 12 (63%) of 19 infants with the GG gen-
otype, 16 (50%) of 32 infants with the GC genotype and
3 (50%) of 6 infants with the CC genotype (p = 0.643).
The incidence of fungal BSI was increased in Caucasian
infants with CC genotype (2/6 (33%)) compared to
infants with the GG (5%) and GC (3%) (p = 0.027) (p =
0.008 comparing CC vs. GC and GG). There were no other
significant differences in organism specific BSI rates
among genotype groups (Table 2). Neither the rates of
non-CONS BSI (GG: 21%, GC: 28%, CC: 33%; p = 0.827)
nor multiple BSI episodes (GG: 21%, GC: 13%, CC: 33%,
p = 0.415) were different among genotype groups.
The IL-6 -174 G/C SNP had no effect on sepsis related-
mortality in Caucasian infants. Overall sepsis mortality
was (GG: 5%, GC: 6%, CC: 17%; p = 0.614). The rate of
sepsis mortality for Caucasian infants with late BSI was
(GG: 8%, GC: 7%, CC: 33%; p = 0.383).
The rate of colonization of ETT tubes and incidence of
nosocomial pneumonia in Caucasian infants were not
affected by the IL-6 -174 G/C polymorphism. Nosocomial
pneumonia rates were: (GG: 5%, GC: 7%, CC: 0%; p =
0.813). ETT colonization rates were: 11/19 (58%) for
infants with the GG genotype, 14/32 (44%) GC genotype
Table 2: Effect of the IL-6 -174 GC Polymorphism on Nosocomial Blood Stream Infections in African- American and Caucasian Infants
African American Caucasian
Organism GG (n = 204) GC (n = 27) CC (n = 2) P value GG (n = 19) GC (n = 32) CC (n = 6) P value
CONS 72 (35) 12 (44) 2 (100) 0.116 11 (58) 11 (34) 3 (50) 0.249
Non CONS 48 (24) 12 (44) 0 0.185 6 (21) 9 (28) 2 (33) 0.827
Fungal 22 (11) 7 (26) 0 0.071 1 (5) 1 (3) 2 (33) 0.027
Gram negative bacilli 16 (8) 1 (4) 0 0.683 3 (16) 5 (16) 0 0.578
Enterococcus sp. 5 (2) 2 (1) 0 0.354 1 (5) 1 (3) 0 0.817
Other 15 (7) 2 (1) 0 0.924 1 (5) 2 (6) 0 0.820
Numbers in parentheses represent percentages of patients with nosocomial blood stream infectionsBMC Medicine 2006, 4:10 http://www.biomedcentral.com/1741-7015/4/10
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and 3/6 (50%) CC genotype (p = 0.620). Organism-spe-
cific colonization rates were not different among genotype
groups.
The incidences of necrotizing enterocolitis (NEC), CSF
infection and infections in other sites were not different
among genotype groups in either African-American or
Caucasian infants.
IL-10 -1082 G/A polymorphism and infectious 
complications
The frequency of the IL-10 -1082A allele in the study pop-
ulation was 0.62. The frequency of the A allele was similar
between African-American (0.63) and Caucasian infants
(0.55) (p = 0.191). Forty (13.7%) infants were
homozygous GG, 145 (47.3%) were heterozygous GA
and 108 (36.9%) were homozygous AA. Distributions of
genotypes were not significantly different between Afri-
can-American and Caucasian infants (p = 0.088). There
were no differences in the frequency of the IL-10 -1082 A
allele between study infants and ethnically matched con-
trol (term) infants [see Additional File 1]. However, the
frequency of the A allele was significantly different
between Caucasian and African-American controls [see
Additional File 1].
Birth weight, gestational age, gender, TA isolation of Uu or
Mh and need for surfactant replacement were not differ-
ent among genotype groups in either Caucasian or African
American infants.
The IL-10 -1082A allele was associated with an increased
incidence of late BSI in our study infants. One or more
episodes of late BSI developed in 14 (35%) of 40 infants
with the GG genotype, 71 (49%) of 145 infants with the
GA genotype and 63 (58%) of 108 infants with the AA
genotype (p = 0.036). In infants who had the A allele (AA
or GA genotypes) the incidence of late BSI was 134/253
(53%) compared to 14/40 (35%) in infant who were
homozygous GG (RR 2.1, 95% CI: 1.04–4.19, p = 0.035).
Although they were not statistically significant, similar
trends were observed when African-American and Cauca-
sian infants were analyzed separately [see Additional File
2, Additional File 3, Additional File 4]. There were no sig-
nificant differences in organism-specific BSI rates among
genotype groups (Table 3). The rates of non-CONS BSI
(GG: 15%, GA: 40%, AA: 26%; p = 0.676) or multiple BSI
episodes (GG: 10%, GA: 16%, AA: 18%, p = 0.528) were
not different among genotype groups. There was a trend
towards increased incidence of non-CONS BSI in infants
with the IL-10 -1082A allele (5/40 infants with GG com-
pared to 66/253 infants GA/AA; p = 0.062).
The IL-10 -1082 G/A SNP had no effect on sepsis-related
mortality. Overall sepsis mortality was: GG: 3%, GA: 6%,
AA: 6% (p = 0.721). Sepsis mortality in infants with late
BSI was: GG: 7%, GA: 11%, AA: 10% (p = 0.877).
The IL-10 -10814 G/A SNP did not affect ETT colonization
or incidence of nosocomial pneumonia. Nosocomial
pneumonia rates were: (GG: 11%, GA: 6%, A: 9%; p =
0.620). ETT colonization rates were: 18/40 (45%) for
infants with the GG genotype, 74/145 (51%) GA geno-
type, and 53/108 (49%) AA genotype (p = 0.791). Organ-
ism-specific colonization rates were not different among
genotype groups.
The incidences of necrotizing enterocolitis (NEC), CSF
infection and infections in other sites were also not differ-
ent among genotype groups in either African-American or
Caucasian infants.
CD14 -260 C/T polymorphism and infectious 
complications
The frequency of the CD14-260T allele in the study popu-
lation was 0.33. The frequency of the T allele was similar
between African-American (0.32) and Caucasian infants
(0.39) (p = 0.151). One hundred and thirty-two (45%)
infants were homozygous CC, 128 (44.2%) were hetero-
zygous CT and 33 (11.3%) were homozygous TT. The fre-
Table 3: Effect of the IL-10 -1082 GA Polymorphism on Nosocomial Blood Stream Infections in African- American and Caucasian 
Infants
African American Caucasian
Organism GG (n = 27) GA (n = 118) AA (n = 88) P value GG (n = 13) GA (n = 25) AA (n = 19) P value
CONS 8 (30) 45 (38) 33 (38) 0.703 4 (31) 10 (40) 11 (58) 0.276
Non CONS 3 (11) 26 (22) 27 (31) 0.088 2 (15) 10 (40) 5 (26) 0.676
Fungal 2 (7) 13 (11) 14 (16) 0.403 0 2 (8) 2 (11) 0.502
Gram negative bacilli 1 (4) 10 (9) 6 (7) 0.675 1 (8) 4 (16) 3 (16) 0.755
Enterococcus sp. 0 3 (3) 4 (5) 0.440 0 2 (8) 0 0.265
Other 1 (4) 7 (6) 9 (10) 0.376 1 (8) 2 (8) 0 0.242
Numbers in parentheses represent percentages of patients with nosocomial blood stream infectionsBMC Medicine 2006, 4:10 http://www.biomedcentral.com/1741-7015/4/10
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quency of the CD24 -260T allele was significantly greater
in Caucasian term infants than in Caucasian VLBW and
African-American term infants [see Additional File 1].
Birth weight, gestational age, gender, TA isolation of Uu or
Mh and need for surfactant replacement were not differ-
ent among genotype groups in either Caucasian or African
American infants.
The CD14 -260CT SNP had no effect on the overall inci-
dence of late BSI. One or more episodes of late BSI devel-
oped in 63 (48%) of 132 infants with the CC genotype, 66
(52%) of 128 infants with the CT genotype and 19 (58%)
of 33 infants with the CC genotype (p = 0.570). However,
there were significant differences in organism-specific
rates of BSI between African-American and Caucasian
infants (Table 4). In particular, in African-American
infants, Gram-negative BSI was associated with the CC
genotype (Incidence of infection CC: 12%, CT: 2% and
TT: 9%, p = 0.020). There was a trend for non-CONS BSI
to be more frequent in infants with the TT genotype (CC:
24%, CT: 20%, TT: 39%; p = 0.074). Multiple BSI episodes
were more common in the TT genotype group (CC: 17%,
CT: 11%, TT: 30%, p = 0.022). This effect was due to the
strong effect of the TT genotype on the incidence of mul-
tiple BSI in African-American infants (CC: 15%, CT: 11%,
TT: 39%, p = 0.003).
The CD14 -260 CT SNP had no effect on sepsis-related
mortality. Overall sepsis mortality was (CC: 6%, CT: 4%,
TT: 6%; p = 0.709). Sepsis mortality in infants with late
BSI was (CC: 10%, CT: 8%, TT: 20% (p = 0.741).
The rate of colonization of ETT tubes and incidence of
nosocomial pneumonia were not affected by the CD14 -
260 CT SNP. Nosocomial pneumonia rates were: (CC:
11%, CT: 5%, CC: 7%; p = 0.190). ETT colonization rates
were: 66/132 (50%) for infants with the CC genotype, 58/
128 (45%) CT genotype, and 21/33 (64%) TT genotype (p
= 0.170). Organism-specific colonization rates were not
different among genotype groups.
The incidences of necrotizing enterocolitis (NEC), CSF
infection and infections in other sites were not different
among genotype groups in either African-American or
Caucasian infants.
Interactions between IL-10 -1082 G/A and IL-6 -174 G/C 
and incidence of sepsis
Since the IL-10 -1082A and the IL-6 -174C alleles were
associated with an increased incidence of late BSI, the
interaction of these two polymorphisms were examined
on this and other outcomes. The effect of carriage of nei-
ther, either or both of the IL-10 -1082A and the IL-6 -174C
alleles and IL-10 -1082:IL-6 -174 haplotypes was exam-
ined. Eight of the 9 possible haplotypes were present in
our patient population. The IL-10 -1082 GG: IL-6 -174CC
haplotype was not observed. Carriage of both the IL-10 -
1082A and the IL-6 -174C alleles was associated with the
greatest risk of late BSI in the overall population (p =
0.073) (Table 5). The incidences of CONS BSI, non-CONS
BSI, multiple BSI and sepsis-related mortality paralleled
that of the overall late BSI rate but were not significant
(Table 5). This increase in risk was seen primarily in Afri-
can-American infants (p = 0.031) [see Additional File 2
and Additional File 3]. No significant trend between hap-
lotype and risk for sepsis was observed, although the high-
est incidence of late BSI was in infants with the IL-10 -
1082AA: IL-6 -174 CC haplotype [see Additional File 5].
In multivariate analysis (logistic regression), carriage of
the IL-10 -1082 A allele (p = 0.035) but not the IL-6 -174
C allele (p = 0.152) was a significant predictor of late BSI.
Discussion
Genetically determined variation in the magnitude of
inflammatory response may play a role in determining
outcome from serious infections. IL-6 is a pro-inflamma-
tory cytokine associated with the development of shock
and mortality from sepsis [31]. Therefore genetic variants
that influence production of this cytokine may have
important implications in the development of and out-
come from sepsis in the preterm neonate. The frequency
Table 4: Effect of the CD14 -260 CT Polymorphism on Nosocomial Blood Stream Infections in African- American and Caucasian 
Infants
African American Caucasian
Organism CC (n = 109) CT (n = 101) TT (n = 23) P value CC (n = 23) CT (n = 24) TT (n = 10) P value
CONS 34 (31) 39 (39) 13 (57) 0.065 12 (52) 24 (46) 2 (20) 0.224
Non CONS 26 (24) 21 (21) 9 (39) 0.178 6 (26) 4 (17) 4 (40) 0.346
Fungal 14 (13) 11 (11) 4 (17) 0.685 2 (9) 1 (4) 1 (10) 0.765
Gram negative bacilli 13 (12) 2 (2) 2 (9) 0.021 3 (13) 2 (8) 3 (30) 0.250
Enterococcus sp. 3 (3) 2 (2) 2 (9) 0.229 0 2 (8) 0 0.241
Other 5 (5) 8 (8) 4 (17) 0.095 1 (4) 2 (8) 0 0.592
Numbers in parentheses represent percentages of patients with nosocomial blood stream infectionsBMC Medicine 2006, 4:10 http://www.biomedcentral.com/1741-7015/4/10
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of the IL-6 -174 C allele in both Caucasian and African-
American VLBW infants was similar to control term
infants and as described in other populations [19,32,33].
This suggests that this polymorphism has no effect on the
incidence of prematurity or on the need for ventilation at
birth. We found that the IL-6 C allele was associated with
an increased risk for late BSI (all organisms) in African-
American but not Caucasian infants. However, the inci-
dence of fungal BSI was greatly increased in Caucasian
infants with CC genotype compared to infants with GG or
GC. This suggests that the IL-6 -174CC genotype may be a
risk factor for fungal sepsis in specific ethnic groups. How-
ever, because there were relatively few Caucasian patients
with the IL-6 -174 CC genotype (6), caution must be exer-
cised in interpreting this finding. Further studies are
needed to confirm this association.
Earlier studies had suggested that the IL-6 -174 G/C poly-
morphism was either not associated with increased risk of
sepsis, or that VLBW infants who were homozygous GG
were at increased risk of Gram positive sepsis [18,34].
However, the infants in these studies were all or predom-
inately Caucasian. Ethnic differences and small numbers
of Caucasian infants in our study may account for some of
the discrepancies. In addition, our infants were signifi-
cantly smaller, less mature and required mechanical ven-
tilation, factors that significantly increase risk of infection
and may overwhelm any effect of this polymorphism.
There was no effect of the IL-6 -174 G/C polymorphism
on mortality-related sepsis. The Ahrens study did not
address the effect of polymorphisms on sepsis mortality.
In adults, the GG genotype was associated with increased
survival in sepsis, but had no effect on the incidence of
sepsis (intensive care setting) [19].
The role of the IL-6 -174 G/C polymorphism on IL-6 pro-
duction is unclear. The IL-6 -174 C allele has been associ-
ated with decreased transcriptional activity in response to
LPS and IL-1α [33]. The effects of this polymorphism,
however, are more complex and may be stimulus depend-
ent, cell line dependent and different in vivo from in vitro.
In vitro IL-6 production in LPS-stimulated mononuclear
cells is higher in the CC genotype in newborn infants [17].
Following coronary artery bypass surgery the C allele is
associated with increased plasma IL-6, whereas following
vaccination the G allele is associated with increased
plasma IL-6 [35-37]. This complexity is further com-
pounded by additional functional polymorphisms that
are in linkage disequilibrium with the -174 SNP [35,36].
IL-10 downregulates inflammatory mediator production
by stimulated immune and epithelial cells. Production of
IL-10 can have a potentially beneficial effect by dampen-
ing excess inflammatory mediator production in sepsis.
Excessive IL-10 production can, however, lead to the phe-
nomenon of immunoparalysis by inhibiting the response
of macrophages to pathogenic bacteria. The frequency of
the IL-10 -1082 A allele in our ventilated VLBW infants is
similar to that in control term infants and to that
described in the literature [27,34,38-40]. This suggests lit-
tle effect of this allele on either the incidence of preterm
birth or the need for mechanical ventilation at birth. Our
results are consistent with those of Kalish et al. [41], in
which the IL-10 -1082 SNP was not associated with risk of
preterm birth.
The IL-10 -1082A allele (lower IL-10 production) was
associated with a two-fold increase in the incidence of late
BSI in ventilated VLBW infants. Although not statistically
significant, there was a trend towards increased non-
CONS BSI (associated with higher mortality and morbid-
ity) in infants with the A allele. This suggests that a more
robust inflammatory response may protect the host from
invasive disease. There was, however, no effect on sepsis-
related mortality. The effect of the IL-10 -1082 G/A poly-
morphism on the incidence and outcome from infectious
disease has been contradictory and may be organism-spe-
cific or vary according to ethnicity. There was no effect of
the IL-10 -1082 G/A polymorphism on the incidence of
invasive meningococcal disease, but disease severity and
mortality were associated with the AA genotype [27]. In
contrast, the G allele was associated with the development
of septic shock in pneumococcal sepsis and severity of the
systemic inflammatory response in community acquired
Table 5: IL-10 -1082 A and IL-6 174C Allele Carriage on Nosocomial Blood Stream Infections
Carriage of IL-10 -1082 A and IL-6 174C Alleles
IL-10 A allele – IL-6 
C allele – (n = 31)
IL-10 A allele – IL-6 
C allele + (n = 9)
IL-10 A allele + IL-6 
C allele – (n = 195)
IL-10 A allele + IL-6 
C allele + (n = 58)
P value
Late BSI (all organisms) 11 (36) 3 (33) 98 (50) 36 (62) 0.073
CONS 10 (32) 2 (22) 41 (36) 12 (44) 0.476
Non Cons 3 (10) 2 (22) 23 (20) 10 (37) 0.166
Multiple BSI 3 (10) 1 (11) 17 (15) 6 (22) 0.760
Mortality from sepsis 1 (3) 0 6 (5) 2 (7) Na
Numbers in parentheses represent percentages na Not able to calculateBMC Medicine 2006, 4:10 http://www.biomedcentral.com/1741-7015/4/10
Page 8 of 11
(page number not for citation purposes)
pneumonia, whereas there was no association between
genotype and risk of infection [23,42]. In the VLBW
infant, an earlier smaller study showed no effect of the IL-
10 -1082 G/A polymorphism on development of sepsis
[34].
The role of polymorphic variation in the IL-10 gene and
IL-10 production is unclear. Variation in IL-10 production
in relation to the IL-10 -1082 SNP is affected by the nature
of inducing stimulus and association of other polymor-
phisms [26,39,40,43-46]. The IL-10 -1082 SNP is in link-
age disequilibrium with two other SNPs (-819 C/T and -
592 C/A) and appears in three haplotypes [26,47,48]. The
GCC haplotype (G at position -1082, C at position -819,
C at -592) is associated with high IL-10 secretion, while
the ACC and ATA haplotypes are associated with interme-
diate and low IL-10 secretion respectively [49]. The -2849
A/G SNP also affects IL-10 production functionally and
should be studied [40,43,44].
Genetic variation in the ability to recognize and respond
to invading organisms may also significantly influence the
development of and outcome from infection. CD14 is an
important component of innate immunity and plays a
role in recognizing both Gram negative and positive
organisms. We found that the CD14 -260 C/T SNP did not
alter the overall risk for BSI in ventilated VLBW infants.
However, the CC genotype was associated with an
increased incidence of Gram negative BSI in African-
American infants, suggesting a potential role for this pol-
ymorphism in determining risk for certain types of infec-
tion or in specific ethnic groups. In addition, multiple BSI
episodes were more common in infants with the TT geno-
type owing to the strong effect of the TT genotype on the
incidence of multiple BSI in African-American infants.
Ahrens et al. demonstrated no association between this
SNP and sepsis or sepsis mortality in VLBW Caucasian
infants [18] The current study extends those findings by
examining a higher risk group (ventilated) of infants with
different ethnic backgrounds. In other studies involving
primarily Caucasian adults, the CD14 -260 C/T polymor-
phism does not seem to have a major influence on the risk
for or outcome from sepsis [50,51]. Only a single study
suggested that the TT genotype (increased CD14) was
associated with the development of septic shock and mor-
tality [10]. Increased soluble CD14 concentrations were
associated with mortality from Gram-negative septic
shock in earlier studies [52].
In Caucasians the CD14 -260 T allele was significantly less
frequent in VLBW infants than in term infants, suggesting
a potential role for this polymorphism in premature birth.
The role of CD14 polymorphisms in prematurity has not
been studied but a larger prior study reported by Hartel et
al. does not support a role for the CD14 -260CT SNP [53].
The frequency of the CD14 -260 T allele in our control
population is similar to that reported in other control
Caucasian populations (both adult and term infants),
which varied between 0.352 and 0.548 [10,53,54]. The
CD14 -260T allele was significantly more frequent in Cau-
casian control infants than in African-American controls,
consistent with other reports [55]. The CD14 -260T allele
frequency in African-American infants (both VLBW and
term) was similar to that reported in the literature [56,57].
In contrast to that seen in Caucasians, no effect of the
CD14 -260CT polymorphism on prematurity was seen in
among African-American infants.
An individual's risk for developing sepsis (and its out-
come) probably depends on interactions of several
genetic factors. Polymorphisms of both pro-inflammatory
(IL-6) and anti-inflammatory cytokines (IL-10) may inter-
act either to increase or to decrease risk. In our study, co-
carriage of both IL-6 -174 C and IL-10-1082 alleles was
associated with a slightly increased risk of late BSI. Multi-
variate analysis, however, suggests that the IL-10 -1082 A
allele is the dominant risk factor.
Other genetic differences may influence risk for and out-
come from sepsis in VLBW infants. We recently reported
that the TNF-α-308A allele did not affect the risk for sepsis
but increased mortality in septic infants [58]. The
3020insC mutation of the NOD2 gene is also associated
with increased risk of sepsis in VLBW infants [18]. Poly-
morphisms in other cytokines, their receptors and other
bacterial pattern recognition molecules have been sug-
gested to alter the course of sepsis and are logical candi-
dates for further study in this population [59-62].
The observations of this retrospective case-controlled
study are limited by selection bias. Our population of
mechanically ventilated infants, most of whom were less
than 1000 grams at birth, is at high risk for infection. As a
result, the incidence of bacteremia/fungemia in our stud-
ied population (47%) is higher than generally reported
for a VLBW population and also higher than for the pop-
ulation of VLBW infants in our NICU (approximately
30%) [3]. Mechanical ventilation and lower birth weight
are known risk factors for late onset sepsis [63]. Because
only infants who were mechanically ventilated were
included, the true impact of the polymorphisms studied
on the incidence of infectious complications of prematu-
rity may be underestimated.
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